2-chloro-n(6)cyclopentyladenosine and glycolipids

2-chloro-n(6)cyclopentyladenosine has been researched along with glycolipids in 1 studies

Compound Research Comparison

Studies (2-chloro-n(6)cyclopentyladenosine)	Trials (2-chloro-n(6)cyclopentyladenosine)	Recent Studies (post-2010) (2-chloro-n(6)cyclopentyladenosine)	Studies (glycolipids)	Trials (glycolipids)	Recent Studies (post-2010) (glycolipids)
252	0	43	19,062	170	5,050

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Batra, VK; Wilson, CN	1

Other Studies

1 other study(ies) available for 2-chloro-n(6)cyclopentyladenosine and glycolipids

Article	Year
Lipopolysaccharide binds to and activates A(1) adenosine receptors on human pulmonary artery endothelial cells. Journal of endotoxin research, 2002, Volume: 8, Issue:4 Topics: Adenosine; Binding, Competitive; Cells, Cultured; Dose-Response Relationship, Drug; Endothelium, Vascular; Glycolipids; Gram-Negative Bacteria; Humans; Interleukin-6; Lipid A; Lipopolysaccharides; Phenethylamines; Pulmonary Artery; Purinergic P1 Receptor Antagonists; Radioligand Assay; Receptors, Purinergic P1; Thromboxane A2; Xanthines	2002

Article

Year

Lipopolysaccharide binds to and activates A(1) adenosine receptors on human pulmonary artery endothelial cells.

Journal of endotoxin research, 2002, Volume: 8, Issue:4

Topics: Adenosine; Binding, Competitive; Cells, Cultured; Dose-Response Relationship, Drug; Endothelium, Vascular; Glycolipids; Gram-Negative Bacteria; Humans; Interleukin-6; Lipid A; Lipopolysaccharides; Phenethylamines; Pulmonary Artery; Purinergic P1 Receptor Antagonists; Radioligand Assay; Receptors, Purinergic P1; Thromboxane A2; Xanthines

2002